Capstone Asset Management’s Dentsply Sirona XRAY Stock Holding History

Capstone Asset Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.93M	Buy	29,802 +4,166	+16%	+$263K	0.05%	404
2017 Q1	$1.6M	Sell	25,636 -973	-4%	-$58.6K	0.04%	459
2016 Q4	$1.54M	Sell	26,609 -884	-3%	-$52.2K	0.04%	463
2016 Q3	$1.63M	Sell	27,493 -287	-1%	-$17.6K	0.05%	447
2016 Q2	$1.72M	Buy	27,780 +2,287	+9%	+$141K	0.05%	412
2016 Q1	$1.57M	Sell	25,493 -8,316	-25%	-$490K	0.05%	469
2015 Q4	$2.06M	Buy	33,809 +250	+0.7%	+$14.9K	0.06%	388
2015 Q3	$1.7M	Sell	33,559 -80	-0.2%	-$4.26K	0.05%	411
2015 Q2	$1.73M	Buy	33,639 +2,680	+9%	+$139K	0.05%	418
2015 Q1	$1.58M	Buy	30,959 +16,880	+120%	+$870K	0.04%	477
2014 Q4	$750K	Buy	14,079 +950	+7%	+$48.3K	0.02%	787
2014 Q3	$599K	Buy	13,129 +210	+2%	+$9.88K	0.02%	888
2014 Q2	$612K	Sell	12,919 -1,942	-13%	-$90.3K	0.02%	916
2014 Q1	$684K	Sell	14,861 -1,250	-8%	-$57.9K	0.02%	834
2013 Q4	$781K	Sell	16,111 -9,856	-38%	-$461K	0.02%	792
2013 Q3	$1.13M	Buy	25,967 +455	+2%	+$19.4K	0.03%	694
2013 Q2	$1.04M	Buy	+25,512	New	+$1.06M	0.03%	682

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Capstone Asset Management's XRAY Position: Q2 2017 in Review

Capstone Asset Management increased its Dentsply Sirona (XRAY) stake by 16% in Q2 2017, buying an estimated $263K and bringing the position to 29,802 shares worth $1.93M. The position accounts for 0.05% of the portfolio, ranked #404.

Capstone Asset Management first reported a position in XRAY in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.06M in Q4 2015. 548 funds tracked by Wall St. Rank hold XRAY as of Q2 2017.

Capstone Asset Management held 29,802 shares of Dentsply Sirona worth $1.93M as of Q2 2017.
Capstone Asset Management bought 4,166 Dentsply Sirona shares in Q2 2017, an estimated $263K.
Dentsply Sirona made up 0.05% of Capstone Asset Management's portfolio in Q2 2017, its #404 holding.
Capstone Asset Management first reported a position in Dentsply Sirona in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's Dentsply Sirona position peaked at $2.06M in Q4 2015.
548 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.